Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

section. Victoza contains the active ingredient liraglutide. It belongs to a group of diabetes drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Victoza is a brand-name medication ...

The most commonly used GLP-1 receptor agonist was semaglutide (Ozempic, Wegovy, Rybelsus; 42.9%), followed by dulaglutide (Trulicity; 38.7%), liraglutide (Victoza, Saxenda; 15.9%), and exenatide ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...

Ozempic and its ilk may do a lot of things, but raising the risk of suicide doesn’t appear to be one of them. Research out ...

A new study presented at the American Academy of Orthopedic Surgeons meeting reveals the need to stop taking GLP-1 agonists ...

THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...

Kidney transplant patients prescribed GLP-1 drugs were 49% less likely to experience organ failure, in which their new kidney stops working and they have to resume dialysis, researchers reported ...